关注
Dawei Chen
Dawei Chen
Shandong cancer hospital
在 mdanderson.org 的电子邮件经过验证
标题
引用次数
引用次数
年份
Pembrolizumab with or without radiotherapy for metastatic non-small-cell lung cancer: a pooled analysis of two randomised trials
WSME Theelen, D Chen, V Verma, BP Hobbs, HMU Peulen, JGJV Aerts, ...
The Lancet Respiratory Medicine 9 (5), 467-475, 2021
3672021
Radiotherapy combined with immunotherapy: the dawn of cancer treatment
Z Zhang, X Liu, D Chen, J Yu
Signal transduction and targeted therapy 7 (1), 258, 2022
2132022
Pembrolizumab with or without radiation therapy for metastatic non-small cell lung cancer: a randomized phase I/II trial
J Welsh, H Menon, D Chen, V Verma, C Tang, M Altan, K Hess, ...
Journal for immunotherapy of cancer 8 (2), 2020
1842020
Low-dose radiation treatment enhances systemic antitumor immune responses by overcoming the inhibitory stroma
HB Barsoumian, R Ramapriyan, AI Younes, MS Caetano, H Menon, ...
Journal for immunotherapy of cancer 8 (2), 2020
1382020
Influence of low-dose radiation on abscopal responses in patients receiving high-dose radiation and immunotherapy
H Menon, D Chen, R Ramapriyan, V Verma, HB Barsoumian, ...
Journal for immunotherapy of cancer 7, 1-9, 2019
1072019
Absolute lymphocyte count predicts abscopal responses and outcomes in patients receiving combined immunotherapy and radiation therapy: analysis of 3 phase 1/2 trials
D Chen, V Verma, RR Patel, HB Barsoumian, MA Cortez, JW Welsh
International Journal of Radiation Oncology* Biology* Physics 108 (1), 196-203, 2020
882020
Interaction between lymphopenia, radiotherapy technique, dosimetry, and survival outcomes in lung cancer patients receiving combined immunotherapy and radiotherapy
D Chen, RR Patel, V Verma, R Ramapriyan, HB Barsoumian, MA Cortez, ...
Radiotherapy and Oncology 150, 114-120, 2020
822020
Phase I trial of pembrolizumab and radiation therapy after induction chemotherapy for extensive-stage small cell lung cancer
JW Welsh, JV Heymach, D Chen, V Verma, TR Cushman, KR Hess, ...
Journal of Thoracic Oncology 15 (2), 266-273, 2020
722020
Response and outcomes after anti-CTLA4 versus anti-PD1 combined with stereotactic body radiation therapy for metastatic non-small cell lung cancer: retrospective analysis of …
D Chen, H Menon, V Verma, C Guo, R Ramapriyan, H Barsoumian, ...
Journal for immunotherapy of cancer 8 (1), 2020
722020
Role of mitochondria in cancer immune evasion and potential therapeutic approaches
K Klein, K He, AI Younes, HB Barsoumian, D Chen, T Ozgen, S Mosaffa, ...
Frontiers in immunology 11, 573326, 2020
702020
Phase 1/2 trial of pembrolizumab and concurrent chemoradiation therapy for limited-stage SCLC
JW Welsh, JV Heymach, C Guo, H Menon, K Klein, TR Cushman, ...
Journal of Thoracic Oncology 15 (12), 1919-1927, 2020
692020
SHP-2 and PD-L1 inhibition combined with radiotherapy enhances systemic antitumor effects in an anti–PD-1–resistant model of non–small cell lung cancer
D Chen, HB Barsoumian, L Yang, AI Younes, V Verma, Y Hu, H Menon, ...
Cancer immunology research 8 (7), 883-894, 2020
692020
Results of a phase 1/2 trial of chemoradiotherapy with simultaneous integrated boost of radiotherapy dose in unresectable locally advanced esophageal cancer
D Chen, H Menon, V Verma, SN Seyedin, JA Ajani, WL Hofstetter, ...
JAMA oncology 5 (11), 1597-1604, 2019
662019
Screening differential circular RNA expression profiles reveal that hsa_circ_0128298 is a biomarker in the diagnosis and prognosis of hepatocellular carcinoma
D Chen, C Zhang, J Lin, X Song, H Wang
Cancer management and research, 1275-1283, 2018
612018
High-dose irradiation in combination with non-ablative low-dose radiation to treat metastatic disease after progression on immunotherapy: Results of a phase II trial
RR Patel, K He, HB Barsoumian, JY Chang, C Tang, V Verma, ...
Radiotherapy and Oncology 162, 60-67, 2021
572021
Combination treatment with radiotherapy and a novel oxidative phosphorylation inhibitor overcomes PD-1 resistance and enhances antitumor immunity
D Chen, HB Barsoumian, G Fischer, L Yang, V Verma, AI Younes, Y Hu, ...
Journal for immunotherapy of cancer 8 (1), 2020
552020
Use of multi-site radiation therapy for systemic disease control
RR Patel, V Verma, HB Barsoumian, MS Ning, SG Chun, C Tang, ...
International Journal of Radiation Oncology* Biology* Physics 109 (2), 352-364, 2021
432021
Preoperative to postoperative change in neutrophil-to-lymphocyte ratio predict survival in colorectal cancer patients
D Guo, A Han, W Jing, D Chen, F Jin, M Li, L Kong, J Yu
Future oncology 14 (12), 1187-1196, 2018
422018
Combined treatment of non‐small cell lung cancer using radiotherapy and immunotherapy: challenges and updates
S Shang, J Liu, V Verma, M Wu, J Welsh, J Yu, D Chen
Cancer Communications 41 (11), 1086-1099, 2021
402021
Total lymphocyte count, neutrophil–lymphocyte ratio, and platelet–lymphocyte ratio as prognostic factors in advanced non–small cell lung cancer with chemoradiotherapy
X Song, D Chen, M Yuan, H Wang, Z Wang
Cancer management and research, 6677-6683, 2018
392018
系统目前无法执行此操作,请稍后再试。
文章 1–20